Cassava Sciences, Inc.
SAVA
$2.73
$0.155.81%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -341.09% | 1,718.52% | |||
| Gross Profit | 341.09% | -1,718.52% | |||
| SG&A Expenses | -106.71% | -69.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -38.26% | -48.34% | |||
| Operating Income | 38.26% | 48.34% | |||
| Income Before Tax | 1.24% | -553.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.24% | -553.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.24% | -553.99% | |||
| EBIT | 38.26% | 48.34% | |||
| EBITDA | 38.57% | 48.50% | |||
| EPS Basic | 1.48% | -537.24% | |||
| Normalized Basic EPS | 39.22% | -554.26% | |||
| EPS Diluted | 1.48% | -548.00% | |||
| Normalized Diluted EPS | 39.22% | -554.26% | |||
| Average Basic Shares Outstanding | 0.26% | 3.84% | |||
| Average Diluted Shares Outstanding | 0.26% | 3.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
